Pharmacologic cardioversion of chronic atrial fibrillation in the goat by class IA, IC, and III drugs: A comparison between hydroquinidine, cibenzoline, flecainide, and d-sotalol

Journal of Cardiovascular Electrophysiology

Volumn 10, Issue 2, 1999, Pages 178-193

  Wijffels, Maurits C E F ^a   Dorland, Rick ^a   Allessie, Maurits A ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Atrial fibrillation; Conduction velocity; Drugs; Goat; Refractory period; Remodeling; Wavelength

Indexed keywords

ANTIARRHYTHMIC AGENT; CIBENZOLINE; DIHYDROQUINIDINE; FLECAINIDE; FLECAINIDE ACETATE; SOTALOL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARDIOVERSION; COMPARATIVE STUDY; CONTROLLED STUDY; GOAT; HEART ATRIUM CONDUCTION; HEART ATRIUM FIBRILLATION; HEART CYCLE; HEART MUSCLE REFRACTORY PERIOD; INTRAVENOUS DRUG ADMINISTRATION; NONHUMAN; PRIORITY JOURNAL; QRS COMPLEX; QT INTERVAL; RR INTERVAL;

EID: 0033007822     PISSN: 10453873     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1540-8167.1999.tb00660.x     Document Type: Article

References (49)

1. Resnekov L, McDonald L: Appraísal of electroconversion in treatment of cardiac dysrhythmias. Br Heart J 1968;30:786-811.
2. Bjerkelund C, Orning O: An evaluation of DC shock treatment of atrial arrhythmias. Acta Med Scand 1968;184:481-491.
3. Fenster PE, Comess KA, Marsh R, et al: Conversion of atrial fibrillation to sinus rhythm by acute intravenous procainamide infusion. Am Heart J 1983;106:501-504.
4. de Nooijer C, Sparting M: Quinidine treatment of chronic lone atrial fibrillation. Clin Cardiol 1990;13:711-714.
5. Madrid AH, Moro C, Marín-Huerta E. et al: Comparison of fiecainide and procainamide in cardioversion of atrial fibrillation. Eur Heart J 1993;14:1127-1131.
6. Halinen MO, Huttunen M, Paakkinen S, et al: Comparison of sotalol with digoxin-quinidine for conversion of acute atrial fibrillation to sinus rhythm (the sotalol-digoxin-quinidine-trial). Am J Cardiol 1995;76:495-498.
7. Crijns HJGM, van Wijk LM, van Gilst WH, et al: Acute conversion of atrial fibrillation to sinus rhythm: Clinical efficacy of flecainide acetate: Comparison of two regimes. Eur Heart J 1988;9:634-638.
8. Suttorp MJ, Kingma HJ, Jessurun ER, et al: The value of class IC antiarrhythmic drugs for acute conversion of paroxysmal atrial fibrillation or flutter to sinus rhythm. J Am Coll Cardiol 1990;16:1722-1727.
9. Bianconi L, Boccadamo R, Pappalardo A, et al: Effectiveness of intravenous propafenone for conversion of atrial fibrillation and flutter of recent onset. Am J Cardiol 1989;64:335-338.
10. Brugada J, Gursoy S, Brugada P, et al: Cibenzoline transforms random re-entry into ordered re-entry in the atria. Eur Heart J 1993;14:267-272.
11. Kühlkamp V, Meerhof J, Schmidt F, et al: Electrophysiologic effects and efficacy of cibenzoline on stimulation-induced atrial fibrillation and flutter and implications for treatment of paroxysmal atrial fibrillation. Am J Cardiol 1990;65:628-632.
12. Teo KK, Harte M, Horgan JH: Sotalol infusion in the treatment of supraventricular tachyarrhythmias. Chest 1985;87:113-118.
13. Horowitz LN, Spielman SR, Greenspan AM, et al: Use of amiodarone in the treatment of persistent and paroxysmal atrial fibrillation resistant to quinidine therapy. J Am Coll Cardiol 1985;6:1402-1407.
14. Gold RL, Haffajee CI, Charos G, et al: Amiodarone for refractory atrial fibrillation. Am J Cardiol 1986;57:124-127.
15. Stambler BS, Wood MA, Ellenbogen KA, et al, and the Ibutilide Repeat Dose Study Investigators: Efficacy and safety of repeated intravenous doses of ibutilide for rapid conversion of atrial flutter or fibrillation. Circulation 1996;93:1613-1621.
16. Wijffels MCEF, Kirchhof CJHJ, Dorland R, et al: Atrial fibrillation begets atrial fibrillation: A study in awake chronically instrumented goats. Circulation 1995;92:1954-1968.
17. Rensma PL, Allessie MA, Lammers WJEP, et al: Length of excitation wave and susceptibility to reentrant atrial arrhythmias in normal conscious dogs. Circ Res 1988;62:395-410.
18. Kirchhof CJHJ, Wijffels M, Brugada J, et al: Mode of action of a new class IC drug (ORG 7797) against atrial fibrillation in conscious dogs. J Cardiovasc Pharmacol 1991;17:116-124.
19. Wang Z, Page PL, Nattel S: Mechanism of flecainide's antiarrhythmic action in experimental atrial fibrillation. Circ Res 1992;71:271-287.
20. Wang J, Bourne GW, Wang Z, et al: Comparative mechanisms of antiarrhythmic drug action in experimental atrial fibrillation: Importance of use-dependent effects on refractoriness. Circulation 1993;88:1030-1044.
21. Wang J, Feng J, Nattel S: Class III antiarrhythmic drug action in experimental atrial fibrillation: Differences in reverse use dependence and effectiveness between d-sotalol and the new antiarrhythmic drug ambasilide. Circulation 1994;90:2032-2040.
22. Olsson SB, Broman H, Hellström C, et al: Adaptation of human atrial muscle repolarisation after high rate stimulation. Cardiovasc Res 1984;19:7-14.
23. Daoud EG, Bogun F, Goyal R, et al: Effect of atrial fibrillation on atrial refractoriness in humans. Circulation 1996;94:1600-1606.
24. Levine JH, Morganroth J, Kadish AH: Mechanisms and risk factors for proarrhythmia with type IA compared with IC antiarrhythmic drug therapy. Circulation 1989;80:1063-1069.
25. Schultz RA, Pretorius PJ, Terblanche M: An electrocardiographic study of normal sheep using a modified technique. Onderstepoort J Vet Res 1972;39:97-106.
26. Moe GK: On the multiple wavelet hypothesis of atrial fibrillation. Arch Int Pharmacodyn Ther 1962;140:183-188.
27. Allessie MA, Lammers WIEP, Bonke FIM, et al: Experimental evaluation of Moe's multiple wavelet hypothesis of atrial fibrillation. In Zipes DP, Jalife J, eds: Cardiac Electrophysiology and Arrhythmias. Grune & Stratton, New York, 1985, pp. 265-275.
28. Moore EN, Spear JF: Natural occurrence and experimental initiation of atrial fibrillation in different animal species. In Kulbertus HE, Olsson SB, Schlepper M, eds: Atrial Fibrillation. Mölndal, Sweden, 1982, pp. 33-41.
29. Henry WL, Morganroth J, Pearlman AS, et al: Relation between echocardiographically determined left atrial size and atrial fibrillation. Circulation 1976;53:273-279.
30. Garrey WE: The nature of fibrillation contraction of the heart: Its relation to tissue mass and form. Am J Physiol 1914;33:397-414.
31. Graffigna A, Pagani F, Minzioni G, et al: Left atrial isolation associated with mitral valve operations. Ann Thorac Surg 1992;54:1093-1098.
32. Shyu K, Cheng J, Chen J, et al: Recovery of atrial function after atrial compartment operation for chronic atrial fibrillation in mitral valve disease. J Am Coll Cardiol 1994;24:392-398.
33. Cox JL, Boineau JP, Schuessler RB, et al: A review of surgery for atrial fibrillation. J Cardiovasc Electrophysiol 1991;2:541-561.
34. Smeets JLRM, Allessie MA, Lammers WJEP, et al: The wavelength of the cardiac impulse and reentrant arrhythmias in isolated rabbit atrium: The role of heart rate, autonomic transmitters, temperature, and potassium. Circ Res 1986;58:96-108.
35. Coumel P: Neurogenic and humoral influences of the autonomic nervous system in the determination of paroxysmal atrial fibrillation. In Attuel P, Olsson SB, Schlepper M, eds: The Atrium in Health and Disease. Futura Publishing Co., Armonk, NY, 1989, pp. 213-232.
36. Farges JP, Ollagnier M, Faucon G: Influence of acetylcholine, isoproterenol, quinidine and ouabain on effective refractory periods of atrial and ventricular myocardium in the dog. Arch Int Pharmacodyn 1977;227:206-219.
37. Solti F, Vecsey T, Kekési V, et al: The effect of atrial dilatation on the genesis of atrial arrhythmias. Cardiovasc Res 1989;23:882-886.
38. Ravelli F, Allessie MA: Atrial stretch decreases refractoriness and induces atrial fibrillation in the isolated rabbit heart. Circulation 1997;96:1686-1695.
39. Morillo CA, Klein GJ, Jones DL, et al: Chronic rapid atrial pacing: Structural, functional and electrophysiologic characteristics of a new model of sustained atrial fibrillation. Circulation 1995;91:1588-1595.
40. Wijffels MCEF, Kirchhof CJHJ, Dorland R, et al: Electrical remodeling due to atrial fibrillation in chronically instrumented conscious goats: Roles of neurohumoral changes, ischemia, atrial stretch and high rate of electrical activation Circulation 1997;96:3710-3720.
41. Cosio FG, Palacios J, Vidal JM, et al: Electrophysiologic studies in atrial fibrillation. Slow conduction of premature impulses: A possible manifestation of the background for reentry. Am J Cardiol 1983;51:122-130.
42. Ohe T, Matsuhisa M, Kamakura S, et al: Relation between the widening of the fragmented atrial activity zone and atrial fibrillation. Am J Cardiol 1983;52:1219-1222.
43. Kumagai K, Akimitsu S, Kawahira K, et al: Electrophysiological properties in chronic lone atrial fibrillation. Circulation 1991;84:1662-1668.
44. Wijffels M, Dorland R, Killian, et al: Widening of the temporal excitable gap during AF by class I and class III drugs. (Abstract) PACE 1998;21:840.
45. Spinelli W, Hoffman BF: Mechanisms of termination of reentrant atrial arrhythmias by class I and class III antiarrhythmic agents. Circ Res 1989;65:1565-1579.
46. Ortiz J, Nozaki A, Shimizu A, et al: Mechanism of interruption of atrial flutter by moricizine: Electrophysiological and multiplexing studies in the canine sterile pericarditis model of atrial flutter. Circulation 1994;89:2860-2869.
47. The Cardiac Arrhythmia Suppression Trial (CAST) Investigators: Preliminary report: Effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction. N Engl J Med 1989;321:406-412.
48. Waldo AL, Camm AJ, de Ruyter H, et al, for the SWORD Investigators: Effect of d-sotalol on mortality in patient with left ventricular dysfunction after recent and remote myocardial infarction. Lancet 1996;348:7-12.
49. Morganroth J: Risk factors for the development of proarrhythmic events. Am J Cardiol 1987;59:32E-37E.